ELOS : Summary for Syneron Medical Ltd. - Ordinary - Yahoo Finance

U.S. Markets close in 2 hrs 22 mins

Syneron Medical Ltd. (ELOS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.15-0.10 (-1.21%)
As of 1:38 PM EST. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close8.25
Bid8.15 x 1500
Ask8.20 x 300
Day's Range8.10 - 8.50
52 Week Range6.11 - 8.50
Avg. Volume155,539
Market Cap282.89M
PE Ratio (TTM)93.68
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube7 days ago

    ETFs with exposure to Syneron Medical Ltd. : November 28, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Syneron Medical Ltd. Here are 5 ETFs with the largest exposure to ELOS-US. Comparing the performance and risk of Syneron Medical Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Syneron Medical Ltd. :ELOS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016
    Capital Cube12 days ago

    Syneron Medical Ltd. :ELOS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016

    Categories: Yahoo Finance Get free summary analysis Syneron Medical Ltd. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Syneron Medical Ltd. – Cutera, Inc., PhotoMedex, Inc., Cynosure, Inc. Class A, BIOLASE, Inc., ZELTIQ Aesthetics, Inc., Dynatronics Corporation and Valeant Pharmaceuticals International Inc (CUTR-US, PHMD-US, CYNO-US, BIOL-US, ... Read more (Read more...)

  • PR Newswire24 days ago

    Syneron Medical to Participate in the Canaccord Genuity Medical Technologies and Diagnostics Forum

    IRVINE, Calif., Nov. 11, 2016 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that Hugo Goldman, Chief Financial Officer, is scheduled to ...